Testing effectiveness (Phase 2)Study completedNCT01974687
What this trial is testing
Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)
Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 178